AIM
SPPI

Acrospire Investment Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Acrospire Investment Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,455
Closed -$42K – 2627
2017
Q1 		$42K Sell
6,455
-28,846
-82% -$161K 0.03% 1107
2016
Q4 		$156K Buy
35,301
+34,077
+2,784% +$143K 0.06% 570
2016
Q3 		$6K Sell
1,224
-16,540
-93% -$98K ﹤0.01% 1807
2016
Q2 		$117K Buy
17,764
+15,564
+707% +$110K 0.09% 328
2016
Q1 		$14K Buy
+2,200
New +$11.3K 0.01% 1667

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acrospire Investment Management's SPPI Position: Q2 2017 in Review

Acrospire Investment Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2017, closing a stake of 6,455 shares — an estimated $42K sold.

Acrospire Investment Management first reported a position in SPPI in Q1 2016 and held it in 5 quarters. The position peaked at $156K in Q4 2016. 124 funds tracked by Wall St. Rank hold SPPI as of Q2 2017.

  • Acrospire Investment Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 6,455 Spectrum Pharmaceuticals Inc shares in Q2 2017, an estimated $42K.
  • Acrospire Investment Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Spectrum Pharmaceuticals Inc position peaked at $156K in Q4 2016.
  • 124 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.